Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: A randomized controlled study

Author:

Jung Ki Suck,Park Hye Yun,Park So Young,Kim Se Kyu,Kim Young-Kyoon,Shim Jae-Jeong,Moon Hwa Sik,Lee Kwan Ho,Yoo Jee-Hong,Lee Sang Do

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference21 articles.

1. Rodriguez-Roisin R, Rabe K, Anzueto A, et al. Global Initiative for chronic obstructive lung disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet].

2. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease;Canadian Thoracic Society;Can Respir J,2007

3. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease;Mahler;Am J Respir Crit Care Med,2002

4. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease;Szafranski;Eur Respir J,2003

5. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD;Hanania;Chest,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3